mash and semaglutide GLP-1 therapies: a new frontier in treatment Metabolic dysfunction-associated steatotic liver disease

The prescribing information lists breastfeeding as a time to avoid semaglutide or to make a decision between breastfeeding and taking medication based on the importance of the medication to the mother and potential unknown risks to the infant

(03:43): So you'd have efficient lowering of glucose through a dual mechanism with increasing insulin, lowering glucagon, and then it was safe because there wasn't this hypoglycemia you get from insulin

That might not sound like much, but at the loading dose of 0.25 mg, that is a 20% error

One form of this drug, Ozempic, is authorized for sale by Health Canada to manage type 2 diabetes while its counterpart, Wegovy, is indicated for long-term weight management